
    
      The primary objective of this study is to assess the impact of metabolic surgery (Roux-en-Y
      gastric bypass [RYGB] or sleeve gastrectomy [SG]) on composite measure of glycemic control at
      2 years post surgery in a Type 2 Diabetes Mellitus (T2DM) cohort of subjects.
    
  